Reuters logo
Merck & Co reports 1 pct rise in quarterly revenue
July 29, 2016 / 10:56 AM / a year ago

Merck & Co reports 1 pct rise in quarterly revenue

July 29 (Reuters) - Merck & Co Inc reported a 1 percent rise in quarterly revenue, driven by higher sales of its cancer drug, Keytruda.

Net income soared to $1.21 billion, or 43 cents per share, in the second quarter, from $688 million, or 24 cents per share, a year earlier.

The company’s revenue rose to $9.84 billion from $9.79 billion. (Reporting by Ankur Banerjee in Bengaluru; Editing by Maju Samuel)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below